Press release

Theraclion announces today its annual sales for the 2018 financial year.

Theraclion announces €11.8 million new financing package concluded

THERACLION announces presentation of results in benign and malignant breast tumors

First European podium presentation at Congress of the German Society of Phlebology for Theraclions’ Echopulse for varicose veins

Theraclion sells first system to German speaking Switzerland and enlarges its reimbursement coverage in Germany.

Theraclion Achieves Key Milestones with Several German Academic Medical Centers

First patient included in Theraclion’s « Forfait Innovation » study

Theraclion announces a major milestone in its efforts to enter into the varicose veins market: the last patient of the CE marking study has been treated.

Theraclion announces today significant milestones in sales and business development in the German market.

First oncological veterinary patient now cancer free after treatment with Theraclion’s Echopulse